The Effectiveness of Topical Silicone Application Combined With Photoprotection in the Developmen⦠(NCT07387536) | Clinical Trial Compass
RecruitingPhase 4
The Effectiveness of Topical Silicone Application Combined With Photoprotection in the Development of Scarring Following Blepharoplasty
Mexico30 participantsStarted 2025-10-01
Plain-language summary
Assess the efficacy of utilizing topical silicone with photoprotection (Improscar StickĀ® 50) on the quality of healing following upper blepharoplasty, employing the Vancouver and POSAS scales (both patient and observer) over a minimum follow-up period of three months.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The study participants are individuals aged 18 years and older, encompassing both male and female subjects. These participants are undergoing blepharoplasty and have provided their written informed consent to partake in the research.
Exclusion Criteria:
* Individuals with a history of previous surgical procedures on the eyelids, apart from the current blepharoplasty. . Those who have previously undergone intralesional modulation are also considered. Individuals with a known allergy to any components of the product under investigation. The presence of local skin infections in the treatment area. Suspicious skin lesions suggestive of malignancy in the eyelid region. Pregnancy or breastfeeding during the study. - Research subjects who, after being included in the study, do not complete the scheduled clinical follow-up. Research subjects who discontinue the use of the topical treatment before the end of the established period. Voluntary withdrawal of informed consent at any stage of the study. Later detection of exclusion criteria that were not identified during the initial evaluation.
What they're measuring
1
Objetive evaluation
Timeframe: From enrollment to the end of treatment at 3 months
2
Subjective evaluation
Timeframe: From enrollment to the end of treatment at 3 months
Trial details
NCT IDNCT07387536
SponsorInstituto de OftalmologĆa Fundación Conde de Valenciana